Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells attack the central nervous system, causing irreversible damage. Current ...

Multiple sclerosis (MS) is a chronic, often debilitating autoimmune disease that affects the central nervous system (CNS).

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...

In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of them, it remains unclear why this process begins. Researchers have now ...

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), likely contributing to the persistent inflammation characteristic of the ...

A clinical trial in China testing ICP-538, a treatment candidate for MS and other autoimmune diseases, has dosed its first healthy volunteer.

The results of preclinical research headed by a team at Karolinska Institutet have indicated how T cells that play a role in the immune system’s reaction to the common Epstein-Barr virus (EBV) can ...

Amid these staggering projections, there are still many unknowns about neurodegenerative diseases and memory loss, but within ...